Literature DB >> 24255110

Design and formulation of functional pluripotent stem cell-derived cardiac microtissues.

Nimalan Thavandiran1, Nicole Dubois, Alexander Mikryukov, Stéphane Massé, Bogdan Beca, Craig A Simmons, Vikram S Deshpande, J Patrick McGarry, Christopher S Chen, Kumaraswamy Nanthakumar, Gordon M Keller, Milica Radisic, Peter W Zandstra.   

Abstract

Access to robust and information-rich human cardiac tissue models would accelerate drug-based strategies for treating heart disease. Despite significant effort, the generation of high-fidelity adult-like human cardiac tissue analogs remains challenging. We used computational modeling of tissue contraction and assembly mechanics in conjunction with microfabricated constraints to guide the design of aligned and functional 3D human pluripotent stem cell (hPSC)-derived cardiac microtissues that we term cardiac microwires (CMWs). Miniaturization of the platform circumvented the need for tissue vascularization and enabled higher-throughput image-based analysis of CMW drug responsiveness. CMW tissue properties could be tuned using electromechanical stimuli and cell composition. Specifically, controlling self-assembly of 3D tissues in aligned collagen, and pacing with point stimulation electrodes, were found to promote cardiac maturation-associated gene expression and in vivo-like electrical signal propagation. Furthermore, screening a range of hPSC-derived cardiac cell ratios identified that 75% NKX2 Homeobox 5 (NKX2-5)+ cardiomyocytes and 25% Cluster of Differentiation 90 OR (CD90)+ nonmyocytes optimized tissue remodeling dynamics and yielded enhanced structural and functional properties. Finally, we demonstrate the utility of the optimized platform in a tachycardic model of arrhythmogenesis, an aspect of cardiac electrophysiology not previously recapitulated in 3D in vitro hPSC-derived cardiac microtissue models. The design criteria identified with our CMW platform should accelerate the development of predictive in vitro assays of human heart tissue function.

Entities:  

Keywords:  arrhythmia disease model; cardiac toxicity; heart regeneration; microfabrication; tissue engineering

Mesh:

Substances:

Year:  2013        PMID: 24255110      PMCID: PMC3856835          DOI: 10.1073/pnas.1311120110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip.

Authors:  Anna Grosberg; Patrick W Alford; Megan L McCain; Kevin Kit Parker
Journal:  Lab Chip       Date:  2011-11-10       Impact factor: 6.799

2.  Recent concepts for the roles of progenitor/stem cell niche in heart repair.

Authors:  Yuliang Feng; Xi-Yong Yu; Yigang Wang
Journal:  Am J Cardiovasc Dis       Date:  2011-12-15

3.  Development of a drug screening platform based on engineered heart tissue.

Authors:  Arne Hansen; Alexandra Eder; Marlene Bönstrup; Marianne Flato; Marco Mewe; Sebastian Schaaf; Bülent Aksehirlioglu; Alexander P Schwoerer; Alexander Schwörer; June Uebeler; Thomas Eschenhagen
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

Review 4.  Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models.

Authors:  Udo Kraushaar; Thomas Meyer; Dietmar Hess; Lior Gepstein; Christine L Mummery; Stefan R Braam; Elke Guenther
Journal:  Expert Opin Drug Saf       Date:  2011-11-22       Impact factor: 4.250

5.  Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.

Authors:  Steven J Kattman; Alec D Witty; Mark Gagliardi; Nicole C Dubois; Maryam Niapour; Akitsu Hotta; James Ellis; Gordon Keller
Journal:  Cell Stem Cell       Date:  2011-02-04       Impact factor: 24.633

6.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

Authors:  Paul W Burridge; Gordon Keller; Joseph D Gold; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

7.  Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis.

Authors:  Parveen Sharma; Thiruchelvi Shathasivam; Vladimir Ignatchenko; Thomas Kislinger; Anthony O Gramolini
Journal:  Mol Biosyst       Date:  2011-01-18

8.  Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology.

Authors:  Sebastian Schaaf; Aya Shibamiya; Marco Mewe; Alexandra Eder; Andrea Stöhr; Marc N Hirt; Thomas Rau; Wolfram-Hubertus Zimmermann; Lenard Conradi; Thomas Eschenhagen; Arne Hansen
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

9.  The simulation of stress fibre and focal adhesion development in cells on patterned substrates.

Authors:  Amit Pathak; Vikram S Deshpande; Robert M McMeeking; Anthony G Evans
Journal:  J R Soc Interface       Date:  2008-05-06       Impact factor: 4.118

Review 10.  Topological and electrical control of cardiac differentiation and assembly.

Authors:  Nimalan Thavandiran; Sara S Nunes; Yun Xiao; Milica Radisic
Journal:  Stem Cell Res Ther       Date:  2013-02-14       Impact factor: 6.832

View more
  112 in total

Review 1.  Electrical and mechanical stimulation of cardiac cells and tissue constructs.

Authors:  Whitney L Stoppel; David L Kaplan; Lauren D Black
Journal:  Adv Drug Deliv Rev       Date:  2015-07-30       Impact factor: 15.470

Review 2.  Tissue-Engineering for the Study of Cardiac Biomechanics.

Authors:  Stephen P Ma; Gordana Vunjak-Novakovic
Journal:  J Biomech Eng       Date:  2016-02       Impact factor: 2.097

Review 3.  Regenerative medicine: Current therapies and future directions.

Authors:  Angelo S Mao; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

Review 4.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

5.  Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.

Authors:  Oscar J Abilez; Evangeline Tzatzalos; Huaxiao Yang; Ming-Tao Zhao; Gwanghyun Jung; Alexander M Zöllner; Malte Tiburcy; Johannes Riegler; Elena Matsa; Praveen Shukla; Yan Zhuge; Tony Chour; Vincent C Chen; Paul W Burridge; Ioannis Karakikes; Ellen Kuhl; Daniel Bernstein; Larry A Couture; Joseph D Gold; Wolfram H Zimmermann; Joseph C Wu
Journal:  Stem Cells       Date:  2017-11-13       Impact factor: 6.277

6.  Phenotypic Variation Between Stromal Cells Differentially Impacts Engineered Cardiac Tissue Function.

Authors:  Tracy A Hookway; Oriane B Matthys; Federico N Mendoza-Camacho; Sarah Rains; Jessica E Sepulveda; David A Joy; Todd C McDevitt
Journal:  Tissue Eng Part A       Date:  2019-05       Impact factor: 3.845

7.  Inspiration from heart development: Biomimetic development of functional human cardiac organoids.

Authors:  Dylan J Richards; Robert C Coyle; Yu Tan; Jia Jia; Kerri Wong; Katelynn Toomer; Donald R Menick; Ying Mei
Journal:  Biomaterials       Date:  2017-07-12       Impact factor: 12.479

Review 8.  High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.

Authors:  Genevieve Conant; Benjamin Fook Lun Lai; Rick Xing Ze Lu; Anastasia Korolj; Erika Yan Wang; Milica Radisic
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

9.  Recapitulation of microtissue models connected with real-time readout systems via 3D printing technology.

Authors:  Jinah Jang; Dong-Woo Cho
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

10.  Optical Method to Quantify Mechanical Contraction and Calcium Transients of Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Katrina J Hansen; John T Favreau; Joshua R Gershlak; Michael A Laflamme; Dirk R Albrecht; Glenn R Gaudette
Journal:  Tissue Eng Part C Methods       Date:  2017-06-27       Impact factor: 3.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.